Return to homepagePandemic Pact

Laser therapy in patients with malignant neoplasms: reducing risk factors for COVID-19 infection

  • Funded by Decanato de Pesquisa e Inovação - Universidade de Brasilia (DPI)
  • Total publications:0 publications

Grant number: 986798

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $6,040.54

  • Funder

    Decanato de Pesquisa e Inovação - Universidade de Brasilia (DPI)

  • Principal Investigator

    Nilce Santos de Melo

  • Research Location

    Brazil

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)Older adults (65 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The elderly, comorbidities and smokers are the people most at risk for COVID19. The patients assisted by our extension project fall into this group of greatest risk: they have head and neck cancer, are elderly and smokers, in addition to having other comorbidities. For these patients, antineoplastic treatment, and its adverse effects, constitute an even more serious condition for COVID infection19. A specific situation resulting from antineoplastic treatment is the appearance of mucositis. In our project, mucositis is treated with the use of low-power laser, but we do not meet the growing demand. Thus, our proposal is to increase, by means of an extension action, the reach of the laser therapy service of the HuB Oral Health Unit, within the scope of our continuous action extension project.